【発明の名称】A33抗原特異的免疫グロブリン産物を用いるA33抗原を発現する癌の影響を低減する方法

Title:

【発明の名称】A33抗原特異的免疫グロブリン産物を用いるA33抗原を発現する癌の影響を低減する方法

Document Type and Number:

Japanese Patent JP2003527334

Kind Code:

A

Abstract:

The invention is directed to methods of reducing the effects of cancer in a subject by administering to said subject a pharmaceutically effective amount of an anti-cancer agent conjugated to an immunoglobulin product which comprises one or more novel complementarity determining region and framework regions.

More Like This:

JP5780527	How to make circular DNA formed from monomolecular DNA
JP2004135519	PARIETAL-ENDODERM-LIKE CELL LINE AND METHOD FOR ESTABLISHING THE SAME AND METHOD FOR PRODUCING SECRETORY PROTEIN
JP4938688	Polypeptides with cellobiohydrolase activity and polynucleotides encoding them

Inventors:

Barbus, Carlos, F., Three
Raider, Christoph
Litter, guard
Welt, Sydney
Old, Lloyd, Jay.

Application Number:

JP2001532810A

Publication Date:

September 16, 2003

Filing Date:

October 20, 2000

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Ludwig Institute for Cancer Research
Memorial Sloan-Kettering Cancer Center
The Scripts Research Institute

International Classes:

C12N15/09; A61K31/17; A61K31/475; A61K31/513; A61K31/7028; A61K31/7034; A61K38/00; A61K39/395; A61K45/00; A61K47/48; A61K51/00; A61P1/00; A61P35/00; C07K16/30; C07K16/32; (IPC1-7): A61K45/00; A61K31/17; A61K31/475; A61K31/513; A61K31/7028; A61K31/7034; A61K38/00; A61K39/395; A61K47/48; A61K51/00; A61P1/00; A61P35/00

Attorney, Agent or Firm:

Takao Suzuki (3 others)

Previous Patent: 低血圧およびショックの治療または予防

Next Patent: 食用コーティング組成物